Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Naloxone for Ocular Neuropathic Pain Diagnosis
NCT04454281Phase 1Completed
- Start
- Oct 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of naloxone in Ocular Neuropathic Pain (2 arms). Primary endpoint: Pain Response to Hypertonic Saline (Muro 128) drop. Started Oct 2020; status: completed.
02
Drugs
naloxone
03
Conditions
Ocular Neuropathic Pain
Beyond the preview
Go deeper on NCT04454281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04454281.